Tscan Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.33

-0.01 (-2.21%)

As of Sep 29, 3:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +3,325.6% upside

Low Target $7.11

Average Target $11.39

High Target $14.81

Current Price $0.33

Current
$0.33

Target
$11.39

$7.11 $11.39 avg $14.81

Scenario Analysis

Bear Case

$7.11

2,038.3%

Low target

Base Case

$11.39

+3,325.6%

Avg target

Bull Case

$14.81

+4,354.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.57

-87.1% from high

52-Week Low

$0.29

+14.6% from low

Target vs 52W High

$11.39

+343.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.6%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.8%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.5%